Navigation Links
Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention

BOTHELL, Wash., April 18, 2007 /PRNewswire-FirstCall/ -- Helix BioMedix, Inc. today announced that Timothy Falla, Ph.D, Chief Scientific Officer, will present an update on the company's new generation of small molecule peptide (lipohexapeptide) technology at the BIO International Convention. The convention will take place at the Boston Convention & Exhibition Center in Boston, MA from May 6th through 9th. Dr. Falla's presentation is scheduled for Wednesday, May 9th, Room D at 10:00 am.

Dr. Falla's presentation will discuss the company's research on the potential of lipohexapeptides as broad spectrum anti-infectives in the prevention of wound infections caused by multiple-resistant hard to treat pathogens such as Pseudomonas aeruginosa in burns, Staphylococcus aureus in surgical wounds and Acinetobacter baumannii in trauma wounds. The company's lipohexapeptides are designed specifically to overcome the disadvantages that have hampered the industry's previous attempts to develop therapeutic antimicrobial peptides. These 'new generation' peptides are excellent drug candidates due to their low toxicity, attractive cost of goods profile, and evidence of efficacy in both bacterial and fungal infection models.

Helix BioMedix's peptides are also currently bringing value-added performance benefits to the cosmeceutical and personal care markets in the areas of anti-acne and anti-aging skin care. The company believes that an increasing number of industry leaders and skin care clinicians are identifying peptides as the next generation of cosmetic skin care technology and the company's proprietary peptides are being incorporated into a growing number of products through various licensing agreements.

Helix BioMedix will be participating in the BIO Business Forum Partnering Program. In 2007, Helix BioMedix has plans to accelerate its entry into the arena of pharmaceutical topical anti-infectives with
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
2. Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
5. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
6. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
7. 2007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. New Information on the Potential of Plasmin Shared at ISTH Congress
10. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
(Date:5/4/2015)... N.J. , May 4, 2015  Oncobiologics, ... commercializing monoclonal antibody (mAb) biosimilars, has completed the ... at its headquarters in Cranbury, New ... Cranbury facility is designed to utilize ... manufacturing at commercial scale.  Through the use of ...
(Date:5/4/2015)... N.Y. , May 4, 2015  Clinical ... Englert , PharmD, has completed preliminary analysis of ... and Schizophrenia. Resources from Clinical Support Services, Inc. ... Reviews (CMR) with patients currently taking psychiatric medications ... The research found that 93% of patients experienced ...
Breaking Medicine Technology:Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... NBI-98854 in 37 tardive dyskinesia patients. For the final analysis, ... and incorrect application of the efficacy assessment protocol. With this ... dyskinesia symptoms at end of two weeks of active treatment ...
... treatment may target hunger at its source, another uses ... stomach and suppress hunger and a third explores the ... Initial results from all these studies were reported at ... in San Francisco, Calif. (Logo: ...
Cached Medicine Technology:Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 2Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 3Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 4Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 5Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 6Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia 7No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 2No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 3No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 4No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 5No Pain, No Gain: Weight Loss, Disc Disease Interventional Radiology Treatments Coming 6
(Date:5/4/2015)... TROY Healthcare Solutions is proud to ... User Group (RUG) Conference in Baltimore, MD from May ... User Group provides an opportunity for clients to gather ... gallery. , In addition to sponsoring the event, TROY ... Atlantic RUG Conference. Attendees can stop by the TROY ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
(Date:5/4/2015)... METTLER TOLEDO has announced an ... Integrity in a GXP Regulated Laboratory ", featuring ... webinar will be presented on May 27, 2015 ... is a critical component of pharmaceutical product quality ... in recent years an increasing number of inspections ...
(Date:5/4/2015)... May 04, 2015 Ticket Down is a ... Champions Cup (ICC) . While the World Cup is ... held every four years, the International Champions Cup is one ... saw the all-time attendance record for soccer in the United ... Big House at the University of Michigan. This year, the ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... of hospital-acquired infections from methicillin-resistant Staphylococcus aureus (MRSA), it ... major hospital trusts // in an attempt to restrict ... NHS Trust is one of the three health care ... Government scheme that would provide tips to combat the ...
... of about 20% of the women who have attained the childbearing ... across the US involving several thousand women. //In the case of ... women belonging to the 16 years to 49 years age group, ... ,The Illinois Chapter of the Sierra Club’s Jack Darin has termed ...
... If appropriate steps are not taken to restrict spread of ... more than 18 million African children would be orphaned // ... 20% increase in just 4 years time. ,The ... by more than 150 health professionals and Government authorities from ...
... The manufacturer of the experimental AIDS drug GS 9137 Gilead ... experiments were successful, as lower levels of HIV were noticed ... // The experiment was conducted over a period of 10 ... effects were also not seen to be of a serious ...
... it disagreed with several provisions of the President's 2007 ... transfer of ownership of oxygen equipment to the beneficiary ... health reimbursement are being opposed by the Association. ... the American Association for Homecare and CEO of Homecare ...
... and Quality has reported that more than $726 million , ... billed to Medicare or Medicaid, government programs intended for the ... statistics, the average charge is $59,600 for Medicare patients and ... burn victims with private insurance is $41,400; and ...
Cached Medicine News:Health News:NHS Trust Would Soon Take On The Hospital Superbug 2Health News:The AIDS Pandemic May Orphan 18 Million African Children By 2010 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: